Sponsor pipeline

Guangzhou Magpie Pharmaceuticals Co., Ltd. clinical trial pipeline

2 active trials 0 recruiting 1 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-15

Primary completion pushed: 2026-03-30 → 2028-03-30
Completion pushed: 2026-06-01 → 2028-06-01

NCT05660863 A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08… · Phase 1

2026-09-12

Primary completion pushed: 2026-03-31 → 2029-03-31
Completion pushed: 2026-08-30 → 2029-08-30

NCT04667013 A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN · Phase 1

Phase 1

NCT ID	Title	Condition	Status	Updated
Phase 1
NCT05660863	A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08…	Pulmonary Arterial Hypertension	Not Yet Recruiting	2026-09-14
NCT04667013	A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN	Healthy	Not Yet Recruiting	2026-09-11

Get alerts when Guangzhou Magpie Pharmaceuticals Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.